Vedolizumab
Vedolizumab
Klass : 2
Visa all info
Skriv ut
Kontakta oss
Moritz MJ et al. Transplant Pregnancy Register International. 2016 Annual Report.
Deshpande NA, Coscia LA, Gomez-Lobo V, Moritz MJ, Armenti VT. Pregnancy after solid organ transplantation: a guide for obstetric management. Rev Obstet Gynecol. 2013;6:116-25.
Coscia LA, Constantinescu S, Moritz MJ, Frank AM, Ramirez CB, Maley WR et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation Clin Transpl. 2010;65-68.
Armenti VT, Constantinescu S, Moritz MJ, Davison JM Pregnancy after transplantation. Transplantation Reviews 2008;22:223-240.
EMA. Entyvio. CHMP Assessment Report 2014-03-27. http://goo.gl/n15FkS
Moens A, van der Woude CJ, Julsgaard M, Humblet E, Sheridan J, Baumgart DC et al. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study. Aliment Pharmacol Ther. 2020;51(1):129-138.
P Wils, P Seksik, C Stefanescu, S Nancey, M Allez, D Laharie, G Pineton De Chambrun, R Altwegg, C Gilletta, L Vuitton, S Viennot, M Serrero, M Fumery, G Savoye, M Collins, F Goutorbe, H Brixi, G Bouguen, N Tavernier, M Boualit, A Amiot, V Abitbol, B Pariente. No severe neonatal and maternal complications in inflammatory bowel diseases patients treated with ustekinumab or vedolizumab during pregnancy. Poster P 447. Abstracts of the 15th Congress of ECCO – European Crohn’s and Colitis Organisation. 2020.
Julsgaard M, Baumgart DC, Baunwall SMD, Hansen MM, Grosen A, Bibby BM et al. Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study. Aliment Pharmacol Ther. 2021.
Chambers CD PhD, Adams J, Xu R, Johnson Diana, Luo Y J. The Vedolizumab Pregnancy Exposure Registry: An OTIS Pregnancy Study Update. Am J Gastroenterol. 2021;116:S367-S368.
Flanagan E, Gibson PR, Wright EK et al. Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure. Aliment Pharmacol Ther. 2020;52(0):1551-1662.
Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis 2010;4:603-5.
- Moritz MJ et al. Transplant Pregnancy Register International. 2016 Annual Report.
- Deshpande NA, Coscia LA, Gomez-Lobo V, Moritz MJ, Armenti VT. Pregnancy after solid organ transplantation: a guide for obstetric management. Rev Obstet Gynecol. 2013;6:116-25.
- Coscia LA, Constantinescu S, Moritz MJ, Frank AM, Ramirez CB, Maley WR et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation Clin Transpl. 2010;65-68.
- Armenti VT, Constantinescu S, Moritz MJ, Davison JM Pregnancy after transplantation. Transplantation Reviews 2008;22:223-240.
- EMA. Entyvio. CHMP Assessment Report 2014-03-27. http://goo.gl/n15FkS
- Moens A, van der Woude CJ, Julsgaard M, Humblet E, Sheridan J, Baumgart DC et al. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study. Aliment Pharmacol Ther. 2020;51(1):129-138.
- P Wils, P Seksik, C Stefanescu, S Nancey, M Allez, D Laharie, G Pineton De Chambrun, R Altwegg, C Gilletta, L Vuitton, S Viennot, M Serrero, M Fumery, G Savoye, M Collins, F Goutorbe, H Brixi, G Bouguen, N Tavernier, M Boualit, A Amiot, V Abitbol, B Pariente. No severe neonatal and maternal complications in inflammatory bowel diseases patients treated with ustekinumab or vedolizumab during pregnancy. Poster P 447. Abstracts of the 15th Congress of ECCO – European Crohn’s and Colitis Organisation. 2020.
- Julsgaard M, Baumgart DC, Baunwall SMD, Hansen MM, Grosen A, Bibby BM et al. Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study. Aliment Pharmacol Ther. 2021.
- Chambers CD PhD, Adams J, Xu R, Johnson Diana, Luo Y J. The Vedolizumab Pregnancy Exposure Registry: An OTIS Pregnancy Study Update. Am J Gastroenterol. 2021;116:S367-S368.
- Flanagan E, Gibson PR, Wright EK et al. Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure. Aliment Pharmacol Ther. 2020;52(0):1551-1662.
- Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis 2010;4:603-5.